Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Medtronic

FDA issues urgent recall on Medtronic surgical tubes

The U.S. Food and Drug Administration has issued a Class I recall, the agency's most serious category, for certain tracheal tubes made by Medtronic.

Tribune News Service · Sep 14, 2022

Check Out What Whales Are Doing With MDT

A whale with a lot of money to spend has taken a noticeably bearish stance on Medtronic. Looking at options history for Medtronic (NYSE:MDT) we detected 17 strange trades.

Benzinga · Aug 30, 2022

Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2022

Benzinga · Aug 24, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Medtronic Stock Keeps Ticking Forward

Medical device maker Medtronic (NYSE: MDT) stock is trading down (-14%) for the year. Medtronic is the world's largest medical device maker with a portfolio of glucose monitors, stents, insulin pumps, pacemakers, and catheters. It serves patients in over 150 countries.

Benzinga · Jul 27, 2022

Ukrainian refugee, 10, fitted with ‘priceless’ and life-changing insulin pump

Dasha Makarenko urgently needed treatment after she fled Ukraine with her family following the Russian invasion.

The Independent UK · Jul 26, 2022

Saudi Arabia, US Sign 18 Agreements in Energy, Other Areas

Saudi Arabia and the United States signed 18 partnership agreements in fields including energy, communications, space and healthcare during a visit by US President Joe Biden. The agreements include deals with US aerospace and defense firms Boeing and Raytheon, as well as healthcare companies Medtronic, Digital Diagnostics, and IQVIA, according…

Asharq Al-Awsat · Jul 16, 2022

Medtronic invests in Israel-based company as precursor to acquisition

Medtronic on Tuesday announced a new partnership with CathWorks, establishing the framework for a $585 million acquisition of the digital health company.

Tribune News Service · Jul 13, 2022

Read news from The Economist, FT, and more,
with one subscription

FDA imposes 'Class 1' recall status on Medtronic's latest HeartWare defect

Federal regulators this week upgraded the recall of Medtronic's HeartWare Ventricular Assist Device to a Class 1 recall, its most serious classification.

Tribune News Service · Jun 9, 2022

12 Analysts Have This to Say About Medtronic

Within the last quarter, Medtronic (NYSE:MDT) has observed the following analyst ratings:

Benzinga · Jun 7, 2022

Check Out What Whales Are Doing With MDT

Someone with a lot of money to spend has taken a bullish stance on Medtronic (NYSE:MDT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga · Jun 3, 2022

6 Stocks To Buy That Are Near 52-Week Lows

Weakness in the S&P 500 has made life unpleasant for investors so far in 2022, but it has also created buying opportunities in a handful of high-quality stocks. Long-term investors looking to buy the dip can find plenty of stocks to buy that are at or near their lowest prices…

Benzinga · Jun 1, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2022

Upgrades

Benzinga · Jun 1, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 27, 2022

Upgrades

Benzinga · May 27, 2022

Medtronic, DaVita To Jointly Form Kidney Health-Focused Company

Medtronic plc (NYSE:MDT) and DaVita Inc (NYSE:DVA) intend to form a new, independent kidney care-focused medical device company (NewCo). NewCo will focus on developing a broad suite of novel kidney care products and solutions, including future home-based products. Medtronic and DaVita will co-own the NewCo, each with equal equity stakes and led by an…

Benzinga · May 26, 2022

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · May 26, 2022

Why Medtronic Shares Are Plunging Today?

Medtronic Plc's (NYSE:MDT) Q4 FY22 sales of $8.09 billion decreased 1% Y/Y on a reported basis but increased 1% organically, missing the consensus of $8.42 billion. The company has forecasted Q4 organic revenue growth of approximately 5.5%. Q4 adjusted EPS of $1.52 increased 2%, missing the analyst consensus of $1.56. Medtronic's heart device…

Benzinga · May 26, 2022

Medtronic: Q4 Earnings Insights

Medtronic (NYSE:MDT) reported its Q4 earnings results on Thursday, May 26, 2022 at 06:45 AM. Here's what investors need to know about the announcement.

Benzinga · May 25, 2022

Medtronic's Earnings: A Preview

Medtronic (NYSE:MDT) is set to give its latest quarterly earnings report on Thursday, 2022-05-26. Here's what investors need to know before the announcement. Analysts estimate that Medtronic will report an earnings per share (EPS) of $1.56.

Benzinga · May 17, 2022

4 Analysts Have This to Say About Medtronic

Within the last quarter, Medtronic (NYSE:MDT) has observed the following analyst ratings:

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com · May 5, 2022

2 Wide-Moat Stocks to Add to Your Portfolio Right Now

The major stock market indexes surged yesterday after the Fed Reserve raised benchmark interest rates by half a percentage point. However, the stock market is expected to remain under pressure at least in the near term on continuing macroeconomic and geopolitical concerns. So, we think it could be wise to…

Benzinga · Apr 27, 2022

Acutus Medical Stock Soars On Debt Refinancing, Divestiture Of Left-Heart Access Portfolio

Acutus Medical Inc (NASDAQ:AFIB) shares are skyrocketing on a commitment letter from Deerfield Management Company to refinance its existing debt with a new longer-term credit facility. The Company has also agreed to sell its left-heart access portfolio to Medtronic plc (NYSE:MDT). The combination of these two transactions, taken together with the Company’s recently completed restructuring,…

StockNews.com · Apr 26, 2022

Medtronic vs. Edwards Lifesciences: Which Medical Device Stock is a Better Buy?

Growing demand from an aging population to track their diseases and increased focus on critical surgical procedures with lesser COVID-19 pressures on hospitals make the medical devices industry’s prospects bright. Moreover, the integration of emerging technologies and continued innovations should drive the industry’s growth. Therefore, prominent players in this space,…

Benzinga · Apr 26, 2022

Medtronic Recalls Harmony Delivery Catheter Due Risk Of Breaking While Procedure

Medtronic Plc (NYSE:MDT) is recalling the Harmony Delivery Catheter, part of the Transcatheter Pulmonary Valve (TPV), due to the possibility that the bond holding the capsule at the end of the delivery catheter may break during a procedure. Harmony TPV System is used to treat a leaky native or surgically repaired right…

Benzinga · Apr 8, 2022

Medtronic's Portfolio Management Unlikely To Be A 'Magic Bullet,' Says Needham

Needham published a report that pointed to previous comments from Medtronic plc's (NYSE: MDT) management that indicate the potential for changes in the coming year, with a spinoff of a large business considered an option.

StockNews.com · Mar 18, 2022

3 Wide-Moat Stocks That Look Cheap: Biogen, Medtronic, and Bristol-Myers Squibb

: Major stock indices appear heading for weekly gains with the Fed’s first interest rate hike digested easily by investors. However, the market is expected to remain under pressure in the near term. So, because wide-moat companies generally do well in these market conditions, we think cheap wide-moat stocks Bristol-Myers…

Benzinga · Mar 16, 2022

Medtronic's US Trial Of GI Genius Endoscopy Module Reduces Missed Colorectal Polyps By 50%

Medtronic plc (NYSE:MDT) announced final findings from a study that confirmed the effectiveness of the GI Genius intelligent endoscopy module. GI Genius uses AI to aid in detecting colorectal polyps during colonoscopy, potentially helping to prevent colorectal cancer (CRC). The study published in Gastroenterology found that the use of GI Genius in conjunction with…

1 … 4 5 6 7

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.